These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22890844)

  • 1. Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus.
    Rytinki M; Kaikkonen S; Sutinen P; Paakinaho V; Rahkama V; Palvimo JJ
    Mol Cell Biol; 2012 Oct; 32(20):4195-205. PubMed ID: 22890844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central role of SUMOylation in the regulation of chromatin interactions and transcriptional outputs of the androgen receptor in prostate cancer cells.
    Launonen KM; Varis V; Aaltonen N; Niskanen EA; Varjosalo M; Paakinaho V; Palvimo JJ
    Nucleic Acids Res; 2024 Sep; 52(16):9519-9535. PubMed ID: 39106160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
    Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
    Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells.
    Kaikkonen S; Paakinaho V; Sutinen P; Levonen AL; Palvimo JJ
    Mol Endocrinol; 2013 Feb; 27(2):212-23. PubMed ID: 23192983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation.
    Sutinen P; Rahkama V; Rytinki M; Palvimo JJ
    Mol Endocrinol; 2014 Oct; 28(10):1719-28. PubMed ID: 25127374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.
    Toropainen S; Malinen M; Kaikkonen S; Rytinki M; Jääskeläinen T; Sahu B; Jänne OA; Palvimo JJ
    Nucleic Acids Res; 2015 Jan; 43(2):848-61. PubMed ID: 25552417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation.
    Mukherjee S; Thomas M; Dadgar N; Lieberman AP; Iñiguez-Lluhí JA
    J Biol Chem; 2009 Aug; 284(32):21296-306. PubMed ID: 19497852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner.
    Sutinen P; Malinen M; Heikkinen S; Palvimo JJ
    Nucleic Acids Res; 2014 Jul; 42(13):8310-9. PubMed ID: 24981513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of androgen receptor SUMOylation.
    Rytinki MM; Kaikkonen S; Sutinen P; Palvimo JJ
    Methods Mol Biol; 2011; 776():183-97. PubMed ID: 21796528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO-3 enhances androgen receptor transcriptional activity through a sumoylation-independent mechanism in prostate cancer cells.
    Zheng Z; Cai C; Omwancha J; Chen SY; Baslan T; Shemshedini L
    J Biol Chem; 2006 Feb; 281(7):4002-12. PubMed ID: 16361251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO-specific protease 1 modulates cadmium-augmented transcriptional activity of androgen receptor (AR) by reversing AR SUMOylation.
    Wu R; Cui Y; Yuan X; Yuan H; Wang Y; He J; Zhao J; Peng S
    Toxicol Lett; 2014 Sep; 229(2):405-13. PubMed ID: 25014244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor- and PIAS1-regulated gene programs in molecular apocrine breast cancer cells.
    Malinen M; Toropainen S; Jääskeläinen T; Sahu B; Jänne OA; Palvimo JJ
    Mol Cell Endocrinol; 2015 Oct; 414():91-8. PubMed ID: 26219822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO-1, human male germ cell development, and the androgen receptor in the testis of men with normal and abnormal spermatogenesis.
    Vigodner M; Ishikawa T; Schlegel PN; Morris PL
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1022-33. PubMed ID: 16352666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs.
    Mukherjee S; Cruz-Rodríguez O; Bolton E; Iñiguez-Lluhí JA
    J Biol Chem; 2012 Sep; 287(37):31195-206. PubMed ID: 22829593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).
    Poukka H; Karvonen U; Janne OA; Palvimo JJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14145-50. PubMed ID: 11121022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
    Nishida T; Yasuda H
    J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation.
    Yang Y; Tse AK; Li P; Ma Q; Xiang S; Nicosia SV; Seto E; Zhang X; Bai W
    Oncogene; 2011 May; 30(19):2207-18. PubMed ID: 21242980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling truncated AR expression in a natural androgen responsive environment and identification of RHOB as a direct transcriptional target.
    Tsai HC; Boucher DL; Martinez A; Tepper CG; Kung HJ
    PLoS One; 2012; 7(11):e49887. PubMed ID: 23209612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer.
    Bahnassy S; Thangavel H; Quttina M; Khan AF; Dhanyalayam D; Ritho J; Karami S; Ren J; Bawa-Khalfe T
    Cell Commun Signal; 2020 Sep; 18(1):154. PubMed ID: 32948192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.